Results 251 to 260 of about 308,174 (298)

Optimising HIV drug resistance testing laboratory networks in Kenya: insights from systems engineering modelling. [PDF]

open access: yesBMJ Open
Wang Y   +7 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

HIV Drug Resistance

2023
Abstract According to the Centers for Disease Control and Prevention (2022), approximately 35% of persons with diagnosed HIV infection in the United States do not have a suppressed viral load, underscoring ongoing gaps in HIV care—many of which were exacerbated with the COVID-19 pandemic.
Carolyn Chu   +2 more
openaire   +1 more source

HIV Drug Resistance

Annual Review of Pharmacology and Toxicology, 1992
Infection with human immunodeficiency virus (HIV) is a chronic process with persistent, high rates of replication. The virus exhibits high rates of mutation over time within the same individual. It is thus not surprising that drug-resis­ tant mutants of HIV emerge under the selective pressure of prolonged chemotherapy, especially with the knowledge of ...
openaire   +3 more sources

Selection of drug-resistant HIV

Trends in Microbiology, 1999
Resistance to antiretroviral drugs by HIV develops from competition among several different virus variants within an individual. Recent studies have measured the changing proportions of HIV populations, which differ by single nucleic acids, under the selective pressures exerted by the addition or removal of antiretroviral drugs.
P R, Harrigan, C S, Alexander
openaire   +2 more sources

Understanding HIV-1 Drug Resistance

Therapeutic Drug Monitoring, 2004
Infection with drug-resistant HIV-1 may result from the acquisition of mutant strains or from their selection within the individual; either can compromise the efficacy of antiretroviral therapy (ART). Drug-resistance testing is recommended to assist in the choice of ART.
Lisa M, Frenkel, Nicole H, Tobin
openaire   +2 more sources

Testing for HIV-1 drug resistance

Molecular Diagnosis, 2001
Viral resistance to antiretroviral agents may limit the efficacy of current treatment regimens for HIV-1 infection. The mutational patterns underlying resistance to each antiretroviral agent are often quite diverse, and cross-resistance patterns in each of the currently available classes are complex.
G J, Hanna, A M, Caliendo
openaire   +2 more sources

HIV Drug Resistance Testing

2010
HIV genotypic resistance testing has become a routine test informing the management of HIV-positive patients. This chapter describes the background of this testing and provides a protocol for undertaking the assay by a home-brew method. Methods for interpretation of the data are also outlined.
openaire   +2 more sources

Adherence and HIV Drug Resistance

HIV Clinical Trials, 2004
(2004). Adherence and HIV Drug Resistance. HIV Clinical Trials: Vol. 5, No. 2, pp. 112-115.
openaire   +3 more sources

Global HIV drug resistance surveillance

Scandinavian Journal of Infectious Diseases, 2003
The transmission of drug-resistant strains of human immunodeficiency virus (HIV) is of increasing concern in countries where antiretroviral therapy is widely used and does not spare countries where highly effective antiretroviral therapy has been recently introduced.
openaire   +2 more sources

Home - About - Disclaimer - Privacy